Fragment-Based Drug Discovery Market Is Expected to Attain a CAGR of 14.4% During 2015 to 2023
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Combinational chemistry and high-throughput screening are some of the more recently introduced practices that have helped make fragment-based drug discovery programs a lot faster and cheaper than before.
View full press release